Stepped-up Nucynta sales push starts paying off for Depomed

Tracy Staton

's relaunch of the franchise–purchased earlier this year from Johnson & Johnson–is off to a running start, the company said last week with its Q3 earnings announcement. And it expects that momentum to carry it all the way to blockbuster land.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS